SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (8474)1/22/2002 2:55:23 AM
From: VAUGHN  Read Replies (3) | Respond to of 14101
 
Gentlemen

Would someone please explain two things to me?

1. What can possibly be taking so long to get HC & FDA approval? It seems we have been waiting for more than 9 months. Can someone explain the holdup to me? Anyone in the know?

2. What promotional efforts have Biovail, BioPharma and a few of its kind undertaken to achieve their current stock prices with no earnings which Dimethaid has not? In short, why are they $14 to $50 to $90 per share while DMX languishes at $5 with volume of 40K? Do the houses simply not believe in management? The product? The discrepancy doesn't make any sense on the face of it...

Your indulgence is appreciated.

Thank you

Vaughn



To: axial who wrote (8474)1/23/2002 5:16:07 PM
From: Cal Gary  Read Replies (1) | Respond to of 14101
 
"I'm stuck on Band-aid 'cause Band-aid stuck on me!" JnJ

I'm going to apply for Business Development with DMX after a OXO acquisition. <g>

I'd approach JnJ with the idea of combining Oxoferin with Band-aid.

Or I'd get in with the R&D department to make Pennsaid a Penn-Band-aid. No more drops, just stick it on.

J.n.J.eh

PS these 3 Banditos, they're a pain in the neck, the back, the butt.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News